Abstract
Summary
Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disruption of the normal blood-retinal barrier which leads to leakage from the perifoveal retinal capillaries causing accumulation of fluid within the intracellular spaces of the retina, mainly in the outer plexiform layer. CME is of two types: pseudophakic and nonpseudophakic cystoid macular edema. Pseudophakic cystoids macular edema is when the cause of occurrence is known while nonpseudophakic is the condition where no specific clinical findings have been observed. Symptoms of cystoids macular edema are blurred or decreased central vision.
LPI (LP Information)' newest research report, the “Cystoid Macular Edema Industry Forecast” looks at past sales and reviews total world Cystoid Macular Edema sales in 2022, providing a comprehensive analysis by region and market sector of projected Cystoid Macular Edema sales for 2023 through 2029. With Cystoid Macular Edema sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cystoid Macular Edema industry.
This Insight Report provides a comprehensive analysis of the global Cystoid Macular Edema landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cystoid Macular Edema portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cystoid Macular Edema market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cystoid Macular Edema and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cystoid Macular Edema.
The global Cystoid Macular Edema market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The cause of CME is not completely known though it may be accompanied by various diseases such as uveitis, vein occlusion or diabetes. It is also known to occur commonly after cataract surgery. Various risk factors associated with cystoids macular edema are penetrating keratoplasty (corneal transplant), retinal surgery, chronic renal failure, retinal vein occlusion, retinitis pigmentosa, systemic medication and topical prostaglandin analogs for glaucoma..No significant racial or sex related predilection exists for this condition. However, cystoids macular edema can occur at any age based on the etiology, though advanced age is at higher risk.
This report presents a comprehensive overview, market shares, and growth opportunities of Cystoid Macular Edema market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Non Steroidal Anti-Inflammatory Drugs
Anti- Vascular Endothelial Growth Factor (VEGF) Agents
Carbonic Anhydrase Inhibitors
Steroids
Segmentation by application
Hospitals
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
EMMES
Fovea Pharmaceuticals
Icon Bioscience
Merck
Sanwa Kagaku Kenkyusho
Novartis
Johns Hopkins University
Wake Forest University
Iladevi Cataract
IOL Research Center
Rabin Medical Center
Kyushu University
Wills Eye Institute
LPI (LP Information)' newest research report, the “Cystoid Macular Edema Industry Forecast” looks at past sales and reviews total world Cystoid Macular Edema sales in 2022, providing a comprehensive analysis by region and market sector of projected Cystoid Macular Edema sales for 2023 through 2029. With Cystoid Macular Edema sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cystoid Macular Edema industry.
This Insight Report provides a comprehensive analysis of the global Cystoid Macular Edema landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cystoid Macular Edema portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cystoid Macular Edema market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cystoid Macular Edema and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cystoid Macular Edema.
The global Cystoid Macular Edema market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The cause of CME is not completely known though it may be accompanied by various diseases such as uveitis, vein occlusion or diabetes. It is also known to occur commonly after cataract surgery. Various risk factors associated with cystoids macular edema are penetrating keratoplasty (corneal transplant), retinal surgery, chronic renal failure, retinal vein occlusion, retinitis pigmentosa, systemic medication and topical prostaglandin analogs for glaucoma..No significant racial or sex related predilection exists for this condition. However, cystoids macular edema can occur at any age based on the etiology, though advanced age is at higher risk.
This report presents a comprehensive overview, market shares, and growth opportunities of Cystoid Macular Edema market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Non Steroidal Anti-Inflammatory Drugs
Anti- Vascular Endothelial Growth Factor (VEGF) Agents
Carbonic Anhydrase Inhibitors
Steroids
Segmentation by application
Hospitals
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
EMMES
Fovea Pharmaceuticals
Icon Bioscience
Merck
Sanwa Kagaku Kenkyusho
Novartis
Johns Hopkins University
Wake Forest University
Iladevi Cataract
IOL Research Center
Rabin Medical Center
Kyushu University
Wills Eye Institute
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cystoid Macular Edema Market Size 2018-2029
2.1.2 Cystoid Macular Edema Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cystoid Macular Edema Segment by Type
2.2.1 Non Steroidal Anti-Inflammatory Drugs
2.2.2 Anti- Vascular Endothelial Growth Factor (VEGF) Agents
2.2.3 Carbonic Anhydrase Inhibitors
2.2.4 Steroids
2.3 Cystoid Macular Edema Market Size by Type
2.3.1 Cystoid Macular Edema Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cystoid Macular Edema Market Size Market Share by Type (2018-2023)
2.4 Cystoid Macular Edema Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Others
2.5 Cystoid Macular Edema Market Size by Application
2.5.1 Cystoid Macular Edema Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cystoid Macular Edema Market Size Market Share by Application (2018-2023)
3 Cystoid Macular Edema Market Size by Player
3.1 Cystoid Macular Edema Market Size Market Share by Players
3.1.1 Global Cystoid Macular Edema Revenue by Players (2018-2023)
3.1.2 Global Cystoid Macular Edema Revenue Market Share by Players (2018-2023)
3.2 Global Cystoid Macular Edema Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cystoid Macular Edema by Regions
4.1 Cystoid Macular Edema Market Size by Regions (2018-2023)
4.2 Americas Cystoid Macular Edema Market Size Growth (2018-2023)
4.3 APAC Cystoid Macular Edema Market Size Growth (2018-2023)
4.4 Europe Cystoid Macular Edema Market Size Growth (2018-2023)
4.5 Middle East & Africa Cystoid Macular Edema Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cystoid Macular Edema Market Size by Country (2018-2023)
5.2 Americas Cystoid Macular Edema Market Size by Type (2018-2023)
5.3 Americas Cystoid Macular Edema Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cystoid Macular Edema Market Size by Region (2018-2023)
6.2 APAC Cystoid Macular Edema Market Size by Type (2018-2023)
6.3 APAC Cystoid Macular Edema Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cystoid Macular Edema by Country (2018-2023)
7.2 Europe Cystoid Macular Edema Market Size by Type (2018-2023)
7.3 Europe Cystoid Macular Edema Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cystoid Macular Edema by Region (2018-2023)
8.2 Middle East & Africa Cystoid Macular Edema Market Size by Type (2018-2023)
8.3 Middle East & Africa Cystoid Macular Edema Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cystoid Macular Edema Market Forecast
10.1 Global Cystoid Macular Edema Forecast by Regions (2024-2029)
10.1.1 Global Cystoid Macular Edema Forecast by Regions (2024-2029)
10.1.2 Americas Cystoid Macular Edema Forecast
10.1.3 APAC Cystoid Macular Edema Forecast
10.1.4 Europe Cystoid Macular Edema Forecast
10.1.5 Middle East & Africa Cystoid Macular Edema Forecast
10.2 Americas Cystoid Macular Edema Forecast by Country (2024-2029)
10.2.1 United States Cystoid Macular Edema Market Forecast
10.2.2 Canada Cystoid Macular Edema Market Forecast
10.2.3 Mexico Cystoid Macular Edema Market Forecast
10.2.4 Brazil Cystoid Macular Edema Market Forecast
10.3 APAC Cystoid Macular Edema Forecast by Region (2024-2029)
10.3.1 China Cystoid Macular Edema Market Forecast
10.3.2 Japan Cystoid Macular Edema Market Forecast
10.3.3 Korea Cystoid Macular Edema Market Forecast
10.3.4 Southeast Asia Cystoid Macular Edema Market Forecast
10.3.5 India Cystoid Macular Edema Market Forecast
10.3.6 Australia Cystoid Macular Edema Market Forecast
10.4 Europe Cystoid Macular Edema Forecast by Country (2024-2029)
10.4.1 Germany Cystoid Macular Edema Market Forecast
10.4.2 France Cystoid Macular Edema Market Forecast
10.4.3 UK Cystoid Macular Edema Market Forecast
10.4.4 Italy Cystoid Macular Edema Market Forecast
10.4.5 Russia Cystoid Macular Edema Market Forecast
10.5 Middle East & Africa Cystoid Macular Edema Forecast by Region (2024-2029)
10.5.1 Egypt Cystoid Macular Edema Market Forecast
10.5.2 South Africa Cystoid Macular Edema Market Forecast
10.5.3 Israel Cystoid Macular Edema Market Forecast
10.5.4 Turkey Cystoid Macular Edema Market Forecast
10.5.5 GCC Countries Cystoid Macular Edema Market Forecast
10.6 Global Cystoid Macular Edema Forecast by Type (2024-2029)
10.7 Global Cystoid Macular Edema Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 EMMES
11.1.1 EMMES Company Information
11.1.2 EMMES Cystoid Macular Edema Product Offered
11.1.3 EMMES Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 EMMES Main Business Overview
11.1.5 EMMES Latest Developments
11.2 Fovea Pharmaceuticals
11.2.1 Fovea Pharmaceuticals Company Information
11.2.2 Fovea Pharmaceuticals Cystoid Macular Edema Product Offered
11.2.3 Fovea Pharmaceuticals Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Fovea Pharmaceuticals Main Business Overview
11.2.5 Fovea Pharmaceuticals Latest Developments
11.3 Icon Bioscience
11.3.1 Icon Bioscience Company Information
11.3.2 Icon Bioscience Cystoid Macular Edema Product Offered
11.3.3 Icon Bioscience Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Icon Bioscience Main Business Overview
11.3.5 Icon Bioscience Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Cystoid Macular Edema Product Offered
11.4.3 Merck Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Sanwa Kagaku Kenkyusho
11.5.1 Sanwa Kagaku Kenkyusho Company Information
11.5.2 Sanwa Kagaku Kenkyusho Cystoid Macular Edema Product Offered
11.5.3 Sanwa Kagaku Kenkyusho Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sanwa Kagaku Kenkyusho Main Business Overview
11.5.5 Sanwa Kagaku Kenkyusho Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Cystoid Macular Edema Product Offered
11.6.3 Novartis Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Johns Hopkins University
11.7.1 Johns Hopkins University Company Information
11.7.2 Johns Hopkins University Cystoid Macular Edema Product Offered
11.7.3 Johns Hopkins University Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Johns Hopkins University Main Business Overview
11.7.5 Johns Hopkins University Latest Developments
11.8 Wake Forest University
11.8.1 Wake Forest University Company Information
11.8.2 Wake Forest University Cystoid Macular Edema Product Offered
11.8.3 Wake Forest University Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Wake Forest University Main Business Overview
11.8.5 Wake Forest University Latest Developments
11.9 Iladevi Cataract
11.9.1 Iladevi Cataract Company Information
11.9.2 Iladevi Cataract Cystoid Macular Edema Product Offered
11.9.3 Iladevi Cataract Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Iladevi Cataract Main Business Overview
11.9.5 Iladevi Cataract Latest Developments
11.10 IOL Research Center
11.10.1 IOL Research Center Company Information
11.10.2 IOL Research Center Cystoid Macular Edema Product Offered
11.10.3 IOL Research Center Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 IOL Research Center Main Business Overview
11.10.5 IOL Research Center Latest Developments
11.11 Rabin Medical Center
11.11.1 Rabin Medical Center Company Information
11.11.2 Rabin Medical Center Cystoid Macular Edema Product Offered
11.11.3 Rabin Medical Center Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Rabin Medical Center Main Business Overview
11.11.5 Rabin Medical Center Latest Developments
11.12 Kyushu University
11.12.1 Kyushu University Company Information
11.12.2 Kyushu University Cystoid Macular Edema Product Offered
11.12.3 Kyushu University Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Kyushu University Main Business Overview
11.12.5 Kyushu University Latest Developments
11.13 Wills Eye Institute
11.13.1 Wills Eye Institute Company Information
11.13.2 Wills Eye Institute Cystoid Macular Edema Product Offered
11.13.3 Wills Eye Institute Cystoid Macular Edema Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Wills Eye Institute Main Business Overview
11.13.5 Wills Eye Institute Latest Developments
12 Research Findings and Conclusion